使用iPSC衍生的视网膜有机体建立人类Leber遗传性视神经病变模型
Kota Aoshima1,2, Yuya Takagi1,2, Michinori Funato2
1Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
Frontiers in cellular neuroscience
|September 29, 2025
概括
研究人员开发了一种人类视网膜器官模型,用于治疗Leber遗传性视神经病变 (LHON),这是一种视力丧失疾病. 这种模型成功地复制了LHON特征,并表明idebenone可以改善视网膜质细胞数量.
科学领域:
- 神经科学是一个神经科学.
- 眼科医生 眼科 眼科
- 干细胞生物学 干细胞生物学
背景情况:
- 勒伯遗传性视神经病 (LHON) 是一种线粒体DNA疾病,导致视力丧失.
- 目前对LHON的理解和治疗发展受到缺乏人类特异性疾病模型的阻碍.
研究的目的:
- 使用患者衍生的诱导多能干细胞 (iPSCs) 建立人类视网膜器官 (RO) 模型的LHON.
- 验证模型复制LHON病理的能力,并评估治疗潜力.
主要方法:
- 产生了来自LHON患者的iPSCs,并将其分化为LHON视网膜器官 (LHON-ROs).
- 在LHON-ROs中评估了RGC数量,轴突密度,线粒体膜潜力和ATP产量.
- 评估了idebenone对LHON-ROs的治疗作用.
主要成果:
- 与对照组相比,LHON-ROs的RGC数量和轴突密度减少.
- 线粒体功能障碍,包括膜潜力降低和ATP产生,在LHON-ROs.中观察到.
- 在LHON-RO模型中,Idebenone治疗显著改善了RGC数量.
结论:
- LHON-RO模型有效地回顾了LHON的关键病理特征.
- 该模型验证了idebenone的治疗疗效,并作为进一步LHON研究的平台.
- 在LHON-ROs中发现了受损的线粒,这表明了新的治疗点.
相关概念视频
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...